Free Trial

Avenue Therapeutics (ATXI) Competitors

Avenue Therapeutics logo
$0.84 +0.13 (+18.69%)
As of 10/14/2025 10:19 AM Eastern

ATXI vs. KPRX, ALBT, TNFA, GOVX, CELZ, GNPX, HCWB, BCTX, QLGN, and CYCN

Should you be buying Avenue Therapeutics stock or one of its competitors? The main competitors of Avenue Therapeutics include Kiora Pharmaceuticals (KPRX), Avalon GloboCare (ALBT), TNF Pharmaceuticals (TNFA), GeoVax Labs (GOVX), Creative Medical Technology (CELZ), Genprex (GNPX), HCW Biologics (HCWB), Briacell Therap (BCTX), Qualigen Therapeutics (QLGN), and Cyclerion Therapeutics (CYCN). These companies are all part of the "pharmaceutical products" industry.

Avenue Therapeutics vs. Its Competitors

Avenue Therapeutics (NASDAQ:ATXI) and Kiora Pharmaceuticals (NASDAQ:KPRX) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, profitability, dividends and analyst recommendations.

17.3% of Avenue Therapeutics shares are owned by institutional investors. Comparatively, 77.0% of Kiora Pharmaceuticals shares are owned by institutional investors. 1.8% of Avenue Therapeutics shares are owned by company insiders. Comparatively, 0.1% of Kiora Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Kiora Pharmaceuticals is trading at a lower price-to-earnings ratio than Avenue Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avenue TherapeuticsN/AN/A-$10.38M-$0.95-0.89
Kiora PharmaceuticalsN/AN/A$3.60M-$2.91-0.94

In the previous week, Kiora Pharmaceuticals had 1 more articles in the media than Avenue Therapeutics. MarketBeat recorded 2 mentions for Kiora Pharmaceuticals and 1 mentions for Avenue Therapeutics. Kiora Pharmaceuticals' average media sentiment score of 0.95 beat Avenue Therapeutics' score of 0.00 indicating that Kiora Pharmaceuticals is being referred to more favorably in the news media.

Company Overall Sentiment
Avenue Therapeutics Neutral
Kiora Pharmaceuticals Positive

Avenue Therapeutics has a beta of 0.04, meaning that its share price is 96% less volatile than the S&P 500. Comparatively, Kiora Pharmaceuticals has a beta of -0.67, meaning that its share price is 167% less volatile than the S&P 500.

Kiora Pharmaceuticals has a consensus price target of $10.00, indicating a potential upside of 264.96%. Given Kiora Pharmaceuticals' stronger consensus rating and higher possible upside, analysts plainly believe Kiora Pharmaceuticals is more favorable than Avenue Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avenue Therapeutics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Kiora Pharmaceuticals
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Kiora Pharmaceuticals' return on equity of -47.17% beat Avenue Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Avenue TherapeuticsN/A -471.57% -296.50%
Kiora Pharmaceuticals N/A -47.17%-34.00%

Summary

Kiora Pharmaceuticals beats Avenue Therapeutics on 9 of the 13 factors compared between the two stocks.

Get Avenue Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATXI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ATXI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ATXI vs. The Competition

MetricAvenue TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$2.26M$1.03B$6.05B$10.52B
Dividend YieldN/A4.84%5.73%4.80%
P/E Ratio0.051.3085.0427.24
Price / SalesN/A186.07571.88227.55
Price / CashN/A17.6437.5761.53
Price / Book0.447.7012.676.74
Net Income-$10.38M-$7.59M$3.32B$276.59M
7 Day Performance12.67%1.59%-1.35%-0.47%
1 Month Performance0.87%28.44%8.09%7.47%
1 Year Performance-59.67%-8.89%78.89%34.58%

Avenue Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATXI
Avenue Therapeutics
2.0507 of 5 stars
$0.84
+18.7%
N/A-58.4%$2.26MN/A0.054News Coverage
KPRX
Kiora Pharmaceuticals
3.2997 of 5 stars
$2.73
-0.4%
$10.00
+266.3%
-11.6%$9.36M$16.02M-0.9410Positive News
ALBT
Avalon GloboCare
1.8492 of 5 stars
$2.39
+2.1%
N/A-30.6%$9.18M$1.33M-0.125
TNFA
TNF Pharmaceuticals
0.0523 of 5 stars
$4.90
-14.8%
N/A-97.6%$9.05MN/A-0.026Negative News
Gap Down
GOVX
GeoVax Labs
2.8036 of 5 stars
$0.55
-3.9%
$8.50
+1,438.2%
-69.9%$8.80M$6.14M-0.2710
CELZ
Creative Medical Technology
1.4202 of 5 stars
$3.41
+0.9%
N/A-23.6%$8.80M$6K-1.075Analyst Forecast
GNPX
Genprex
1.1512 of 5 stars
$0.20
-1.0%
N/A-26.1%$8.68MN/A0.0020News Coverage
Negative News
HCWB
HCW Biologics
1.6451 of 5 stars
$4.03
flat
$35.00
+768.5%
-78.7%$8.66M$2.57M-0.2940
BCTX
Briacell Therap
2.3093 of 5 stars
$12.63
-4.5%
$320.00
+2,433.7%
-91.5%$8.59MN/A-0.158
QLGN
Qualigen Therapeutics
N/A$5.03
flat
N/A-54.8%$8.53MN/A0.0050
CYCN
Cyclerion Therapeutics
2.3332 of 5 stars
$2.55
+6.7%
N/A-3.3%$8.51M$2.17M-3.4530Analyst Forecast

Related Companies and Tools


This page (NASDAQ:ATXI) was last updated on 10/15/2025 by MarketBeat.com Staff
From Our Partners